| 237.67 BATS BZX Real-Time Price As of 1:52pm ET |  -2.62 / -1.09%Today’s Change | 216.12 Today|||52-Week Range 388.67 | -21.02% Year-to-Date |
| Previous close | 240.29 |
| Today’s open | 241.99 |
| Day’s range | 235.92 - 242.40 |
| Volume | 889,735 |
| Average volume (3 months) | 2,224,658 |
| Market cap | $46.3B |
| Earnings growth (last year) | +81.10% |
| Earnings growth (this year) | +12.66% |
| Earnings growth (next 5 years) | +5.50% |
| Revenue growth (last year) | +9.67% |
| P/E ratio | 10.3 |
| Price/Sales | 5.13 |
| Price/Book | 3.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -1.63 | -0.46% |
| EXASExact Sciences Corp | +1.64 | +1.47% |
| TECHBio-Techne Corp | -0.86 | -0.42% |
| NBIXNeurocrine Bioscienc... | -0.96 | -1.19% |
| Next reporting date | July 23, 2019 |
| EPS forecast (this quarter) | $7.50 |
| Annual revenue (last year) | $12.1B |
| Annual profit (last year) | $4.4B |
| Net profit margin | 36.76% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michel Vounatsos |
Chief Financial Officer & Executive Vice President Jeffrey D. Capello |
Corporate headquarters Cambridge, Massachusetts |
